ARTICLE

FindCenter AddIcon

Microdosing’s Micromoment: Consuming Crumb-Size Amounts of Psychedelics—Not to Get High But to Feel More Focused and Creative and Present—Has Moved a Tiny Bit Mainstream.

By Simone Kitchens — 2018

As of one month ago, I knew of just one friend who microdosed; my friend, who is a musician, said he was taking 0.1 grams of mushrooms a few mornings a week so he could finish up an album that had been taking him years.

Read on www.thecut.com

FindCenter Post-Image

An Introduction to MDMA

Once considered the quintessential party drug, MDMA (also known as “ecstasy,” “X,” or “molly”) is now experiencing a surge of interest in a completely different area: psychedelic-assisted psychotherapy.

Article
FindCenter
2022
FindCenter AddIcon
FindCenter Post-Image

An Introduction to LSD

LSD, or lysergic acid diethylamide, is a synthetic drug with potent psychedelic properties. Commonly known as acid, it was originally derived from compounds found in ergot, a fungus that grows on rye.

Article
FindCenter
2022
FindCenter AddIcon
FindCenter Post-Image

Why Microdosing MDMA Could Be A Bad Idea

As the trend of microdosing illustrates, if people want to reap the benefits of a substance, they’ll find the most effective way to do it. Everyone from entrepreneurs to artists are microdosing psychedelics like LSD, psilocybin, and mescaline for spiritual, creative, and productive enhancement.

Article
Patrick Smith
2017
FindCenter AddIcon
FindCenter Post-Image

A Brief History of Psychedelic Psychiatry

In the 1950s a group of pioneering psychiatrists showed that hallucinogenic drugs had therapeutic potential, but the research was halted as part of the backlash against the hippy counterculture.

Article
Mo Costandi
2014
FindCenter AddIcon
FindCenter Post-Image

An Introduction to Psilocybin

With the advent of the psychedelic renaissance occurring currently, many people have become curious about one of the most famous hallucinogens: psilocybin mushrooms. Read on to discover the most important information about these fascinating fungi.

Article
FindCenter
2022
FindCenter AddIcon
FindCenter Post-Image

It’s Time to Start Studying the Downside of Psychedelics

Before psychedelic therapy and services becomes widely available, there needs to be a better understanding of all the ways these experiences can go wrong.

Article
Shayla Love
2022
FindCenter AddIcon
FindCenter Post-Image

FDA Calls Psychedelic Psilocybin a 'Breakthrough Therapy' for Severe Depression

The FDA is helping to speed up the process of researching and approving psilocybin, a hallucinogenic substance in magic mushrooms, to treat major depressive disorder (MDD).

Article
Yasemin Saplakoglu
2019
FindCenter AddIcon
FindCenter Post-Image

Ketamine Therapy Is Going Mainstream. Are We Ready?

The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.

Article
Emily Witt
2021
FindCenter AddIcon
FindCenter Post-Image

I Took Ketamine for My Depression. Things Got Pretty Weird.

My first encounter with ketamine did not go well.

Article
Vanessa Barbara
2021
FindCenter AddIcon
FindCenter Post-Image

Integration, Rippling

In the deep space of the psychedelic experience exists a teaching on unity principle and belonging with the earth.

Article
Francoise Bourzant
2020
FindCenter AddIcon

EXPLORE TOPIC

Microdosing